Adjusted ORs of AF within 30 days after bereavement with specific characteristics versus non-bereaved with the same characteristics. * *The vertical dashed.

Slides:

Advertisements

Similar presentations

CIBIS II Cardiac Insufficiency Bisoprolol Study

Advertisements

Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Habitual Coffee Consumption on Cardiometabolic.

Estimated 24-h urinary excretion of sodium and composite of cardiovascular death.. Figure 3. Estimated 24-h urinary excretion of sodium and composite of.

Case 66 year old male with PMH of HTN, DM, ESRD on renal replacement TIW, stroke in 2011 with right side residual weakness, atrial fibrillation, currently.

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

Copyright © 2011 American Medical Association. All rights reserved.

Fig. 1. Age-dependent distribution of AKI risk factors

Subclinical organ damage Treatment LVH

Association of low eosinophil and lymphocyte counts with different initial presentations of cardiovascular disease over the first 6 months ‘Low eosinophils’

WHI Observational Study: Cardiovascular death in women with hypertension but no history of CVD on monotherapy CVD death Diuretic, HR (95% CI) ACE inhibitor,

Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data by Masao Iwagami, Ben Caplin,

Drug Rate ratio 95% CI Thiazide diuretics 1.0 Reference ACE inhibitors

Volume 93, Issue 4, Pages (April 2018)

Comorbidities in RA and PsA

Dileep Raman et al. JACEP 2017;3:

OR (95% CI) for CHD associated with inflammatory markers before and after adjustment for established risk factors. OR (95% CI) for CHD associated with.

Incidence of all renal events according to achieved BP levels, adjusted for age, gender, duration of diabetes, glycosylated hemoglobin, currently treated.

P2Y12 blockade versus placebo; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.

Wesley T. O’Neal et al. JACEP 2016;2:

Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data by Masao Iwagami, Ben Caplin,

Figure 2 Absolute difference in seasonal peak

Adjusted rate ratios of hospital days and admissions for blacks and Hispanics compared with whites by age group. Adjusted rate ratios of hospital days.

Efficacy and safety outcomes with NOAC compared with warfarin in NOAC patients with 14 457 years of risk and 49 418 warfarin patients with 75 747.

OR (95% CI) for CHD associated with inflammatory markers in all participants and in subsets of non-users of statins or non-users of aspirin therapy. OR.

NAFLD (nonalcoholic fatty liver disease), CVD, and type 2 diabetes: Details of the study design Targher G et al. Diabetes Care 2007;30:

Potassium levels and risk of in-hospital arrhythmias and mortality in patients admitted with suspected acute coronary syndrome Jonas Faxén, Hong Xu,

Estimated HR as a function of absolute change in glycated hemoglobin (HbA1c; from index to measurement 22–26 months after). Estimated HR as a function.

Characteristics of 21,484 Patients With MI Who Survived for >30 Days After Discharge, by Calendar Year - Part I Soko Setoguchi, et al. J Am Coll Cardiol.

(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.

Association between cardiovascular disease, cardiovascular risk factors and chronic obstructive pulmonary disease (COPD) on mortality. Association between.

(A) 1-year mortality in relation to estimated glomerular filtration rate (eGFR), age (n=47 636) and presence of diabetes mellitus (n=47 624). (A) 1-year.

Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.

Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey Maura Marcucci, MD, Gregory Y.H. Lip,

Associations between β-blocker dosage group, predischarge heart rate group, and the primary composite outcome of death or cardiovascular rehospitalisation.

The volume per centre plotted against clinical outcomes which included Hospital Anxiety and Depression Scale (HADS) score, exercise 150 min, smoking, body.

Estimated HR as a function of mean residual of glycated hemoglobin (HbA1c) measurements to the line connecting index HbA1c and HbA1c measurement 22–26 months.

Receiver operating characteristics curve of N-terminal pro-atrial natriuretic peptide plasma levels (dark line) and brain natriuretic peptide (dashed line)

Enrollment of patients.

Forest plot showing the association between center-level characteristics and death-censored technique failure after adjusting for age, sex, race, body.

An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61

Flow chart of search strategy

Antithrombotic strategies in patients on long-term oral anticoagulation therapy undergoing percutaneous coronary intervention. ACS: acute coronary syndrome;

An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61

Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes Steven M. Brunelli, Ravi Thadhani,

Adjusted ORs of AF according to time since bereavement versus non-bereaved in a population from Denmark between 1995 and * *ORs are adjusted for.

Low/moderate intensity statins High intensity statins

Forest plot illustrating the risk ratio of any bleeding and GRADE assessment. AF, atrial fibrillation; DOAC, advent of direct oral anticoagulants; PCI,

Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.

Determinants of moderate Cardiovascular Health Index Score (CHIS) (achieving three or more risk factor targets). Determinants of moderate Cardiovascular.

Prasugrel versus clopidogrel; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.

Percentage of all inpatient episodes for selected cardiovascular conditions, by sex and country of the UK, 2012/2013. Percentage of all inpatient episodes.

Risk for cardiovascular disease and all-cause death according to RHR: (A) as categorical variable (HR≥75 bpm vs HR

Figure 8. Stroke prevention strategy in patients with AF

Figure 1. Decision-making process of stroke prevention in patients with AF from Asia. The decision-making process includes stroke risk evaluation, OAC.

Use of evidence-based cardiac medications before, during and after hospitalisation for the index event in (A) overall ACS population and (B) patients with.

Forest plot illustrating the risk ratio of major bleeding

Multivariable-adjusted HRs and 95% CIs for outcomes for waist circumference. Multivariable-adjusted HRs and 95% CIs for outcomes for waist circumference.

Forest plot illustrating the risk ratio of myocardial infarction

Forest plot illustrating risk ratio of stent thrombosis

Low/moderate intensity statins High intensity statins

Prasugrel and ticagrelor versus clopidogrel; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial.

Adjusted associations between hypertensive disorder of pregnancy subtypes and MI, heart failure and stroke. Adjusted associations between hypertensive.

Adjusted ORs of increasing severity of heartburn at follow-up in reference to baseline from model adjusted for BMI category, CVD history, BDI score >11,

Determinants of moderate Cardiovascular Health Index Score (achieving three or more risk factor targets), stratified by region conventions as in figure.

HR for mortality in ischemic heart disease.

HR for myocardial infarction.

Comparison of heart failure admissions rates per annum (recorded hospital admissions/ population at risk) in western developed countries 1978 to.

Subgroup analysis of associations between daily tea consumption and risk of ischaemic heart disease (IHD) according to potential baseline risk factors.

The CHA(2)DS2-(VASc) stroke risk and HAS-BLED bleeding risk index are calculated by totalling the scores for each risk factor present.68–71 The lower graph.

Presentation transcript:

Adjusted ORs of AF within 30 days after bereavement with specific characteristics versus non-bereaved with the same characteristics. * *The vertical dashed line represents the overall OR for AF within 30 days after bereavement compared with non-bereaved. Adjusted ORs of AF within 30 days after bereavement with specific characteristics versus non-bereaved with the same characteristics. * *The vertical dashed line represents the overall OR for AF within 30 days after bereavement compared with non-bereaved. The ORs (except for CVD and diabetes mellitus (DM)) are adjusted for age, sex and hospital diagnosis for hypertension, ischaemic heart disease, cardiomyopathy, congestive heart failure, hyperthyroidism, diabetes and cardiovascular medication (vitamin K antagonists MB01AA, ACE inhibitors and angiotensin II antagonists MC09, β-blocking agents MC07, lipid-modifying agents MC10, calcium antagonists MC08D, diuretics MC03, nitrates MC01DA, digoxin MC01, antiplatelet agents MB01AC). †Point estimates are given with error bars representing 95% CIs. §Cardiovascular disease: hypertension, ischaemic heart disease, cardiomyopathy, congestive heart failure. ¶DM: according to an algorithm developed on the basis of the Danish National Diabetes Register. ‡Risk of death in partner: corresponding ACCI scores 1 month before index day divided into three categories for statistical comparison. AF, atrial fibrillation; CVD, cardiovascular disease. Simon Graff et al. Open Heart 2016;3:e000367 ©2016 by British Cardiovascular Society